Spots Global Cancer Trial Database for Study of Predictive Factors of Chemoresistance in Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Official Title: Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Study ID: NCT02878122
Conditions
Interventions
Study Description
Brief Summary: Epithelial ovarian cancer (EOC) has a poor prognosis. EOC management requires debulking surgery and chemotherapy based on taxol and carboplatine. Initial response is often good, but most often a recurrence occurred in the first 18 months. Early recurrence signs chemoresistance and palliative treatment. The study of predictive clinical or biological factors is required to adapt therapeutic and develop new treatments.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
LAVOUE, Rennes, , France
Contact Details
Name: LAVOUE Vincent, Pr
Affiliation: Rennes University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
